How will SCHOTT Pharma benefit from new market trends?
“We are constantly expanding our strong market position thanks to a variety of emerging trends offering enormous potential for growth and revenue generation, such as mRNA, GLP-1 drugs, and biologics. Our High-Value Solutions and innovations such as our sterilised products ensure that we are not only responding to these trends but are actively driving demand. Every minute of every day, more than 25,000 injections are provided to patients worldwide through one of our products. And yet, thepotential is far from exhausted.”
Yen Schiffner, Head of Market Intelligence & Training SCHOTT Pharma